Amsterdam, Netherlands

Sander J Van Deventer

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sander J Van Deventer: Innovator in Therapeutic Protein Applications

Introduction

Sander J Van Deventer is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of therapeutic protein applications, particularly in the treatment of conditions related to bacterial endotoxin exposure. With a total of 3 patents to his name, his work has garnered attention in the medical and scientific communities.

Latest Patents

One of Sander's latest patents focuses on the human therapeutic uses of bactericidal/permeability-increasing (BPI) protein products. This patent discloses methods for treating humans who have been exposed to bacterial endotoxin in circulation. The administration of BPI protein products has been shown to result in serologically and hematologically verifiable alleviation of endotoxin-mediated increases in circulating cytokines, fibrinolysis, and coagulation factors. Additionally, changes in lymphocyte counts are observed upon such treatment. The patent also highlights the alleviation of endotoxin-mediated decreases in systemic vascular resistance index (SVRI) and concomitant increases in cardiac index (CI).

Career Highlights

Throughout his career, Sander has worked with various organizations, including Xoma Corporation. His innovative approaches and research have positioned him as a key figure in the development of therapeutic solutions for critical health issues.

Collaborations

Sander has collaborated with notable professionals in his field, including Nadav Friedmann and Patrick J Scannon. These collaborations have further enhanced the impact of his work and contributed to advancements in therapeutic applications.

Conclusion

Sander J Van Deventer is a distinguished inventor whose work in therapeutic protein applications has the potential to significantly improve treatment outcomes for patients exposed to bacterial endotoxins. His contributions to the field are invaluable and continue to inspire further research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…